Scarce Medicinal Plant and Animal Resources Are Being Depleted
The production of extracts from plants and animals is hindered by regional, seasonal, and climatic factors, making stable supply difficult and costs high. For example, the active components in ginkgo leaf extracts fluctuate by up to 30%, directly affecting drug consistency. Additionally, millions of animals are slaughtered annually to extract trace active ingredients for traditional high-value Chinese medicines and treatments for conditions like stroke, cardiovascular, and kidney diseases, posing risks of disease transmission and supply insecurity while conflicting with ecological civilization principles. Moreover, the heavy use of organic solvents in extraction pollutes the environment and risks leaving harmful residues, creating medication safety hazards.
Solution
We decode nature's biological blueprints, reconstructing plant and animal metabolic pathways within microbes. This breakthrough biotechnology replaces traditional extraction methods with cleaner, more efficient, and sustainable production - guaranteeing pharmaceutical quality while conserving precious ecosystems. Every tablet we produce thus becomes a dual promise: protecting human health while healing our planet.
-
Reduce Slaughter
-
Sustainability
-
High Quality
-
Earth Protection
Chemical synthesis of medicinal raw materials is facing increasing challenges
While chemical synthesis boosts production efficiency, it carries significant environmental and safety trade-offs. Industry data reveals that 70% of pharmaceutical APIs depend on chemical synthesis, yet fundamental limitations—including poor reaction selectivity and complex byproduct profiles—compromise drug quality. More critically, these processes typically require heavy metal catalysts (palladium, platinum, etc.), with global consumption reaching hundreds of tons annually. This not only escalates costs but leaves toxic residues that threaten both ecosystem and patient safety. Furthermore, the energy-intensive nature and high pollution footprint of these synthetic pathways present urgent sustainability challenges for the global pharmaceutical industry.
Solution
Mannitol is a functional sugar alcohol widely used in the pharmaceutical industry. Naturally occurring in seaweed, fruits, and plant stems and leaves, it is found in small quantities in nearly all vegetables. Currently, it is primarily produced via chemical hydrogenation.
Through revolutionary biosynthetic technology, we are transforming industry standards as the world's first to achieve industrial-scale bio-manufactured mannitol. Our cost-effective, premium-quality bio-based solution has earned widespread market acceptance while pioneering the shift from chemical hydrogenation to sustainable green production in the mannitol industry.
